Sarah Al-Hajali
Private Equity Investor at Myrisoph Capital, Inc.
Profile
Sarah is an experienced C-suite executive with extensive regional experience in the GCC healthcare industry, having successfully lead a turnaround with attractive investor returns in her position as a CEO of the first private cord blood bank in the region in a JV with the largest European Stem Cell company.
Sarah is a Swedish-Romanian executive with a BSc in Chemical Engineering and a MSc in Biotechnology from Malardalens University in Sweden, as well as an MBA from the London Business School.
Sarah Al-Hajali active positions
| Companies | Position | Start |
|---|---|---|
Myrisoph Capital, Inc.
 Myrisoph Capital, Inc. Investment ManagersFinance Myrisoph Capital, Inc. (Myrisoph Capital) is an independent private equity and venture capital firm founded in 2016. The firm is headquartered in Los Angeles, California. | Private Equity Investor | 30/11/2016 |
Training of Sarah Al-Hajali
| University of Stockholm | Graduate Degree |
| London Business School | Masters Business Admin |
| Mälardalen University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Myrisoph Capital, Inc.
Myrisoph Capital, Inc. Investment ManagersFinance Myrisoph Capital, Inc. (Myrisoph Capital) is an independent private equity and venture capital firm founded in 2016. The firm is headquartered in Los Angeles, California. | Finance |
- Stock Market
- Insiders
- Sarah Al-Hajali
